Alberta Investment Management Corp (AIMCo)’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-53,000	Closed	-$953K	–	1105
2020 Q3	$953K	Sell	53,000 -12,700	-19%	-$263K	0.01%	676
2020 Q2	$1.67M	Buy	65,700 +5,800	+10%	+$125K	0.02%	547
2020 Q1	$1.1M	Buy	59,900 +12,700	+27%	+$247K	0.02%	553
2019 Q4	$1.04M	Sell	47,200 -7,400	-14%	-$149K	0.01%	650
2019 Q3	$784K	Buy	+54,600	New	+$780K	0.01%	685
2019 Q2	–	Sell	-12,800	Closed	-$188K	–	1036
2019 Q1	$188K	Buy	+12,800	New	+$147K	﹤0.01%	866

Other funds holding DRNA

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s DRNA Position: Q4 2020 in Review

Alberta Investment Management Corp (AIMCo) sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2020, closing a stake of 53,000 shares — an estimated $953K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in DRNA in Q1 2019 and held it in 6 quarters. The position peaked at $1.67M in Q2 2020. 173 funds tracked by Wall St. Rank hold DRNA as of Q4 2020.

Alberta Investment Management Corp (AIMCo) reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 53,000 Dicerna Pharmaceuticals, Inc. shares in Q4 2020, an estimated $953K.
Alberta Investment Management Corp (AIMCo) first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2019 and held it in 6 quarters.
Alberta Investment Management Corp (AIMCo)'s Dicerna Pharmaceuticals, Inc. position peaked at $1.67M in Q2 2020.
173 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2020.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q4 2020, filed 16 Feb 2021.